Adis Journals
Browse
Summary slide.png (130.13 kB)
Download file

Efficacy, Safety and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin

Download (130.13 kB)
media
posted on 2021-01-06, 14:32 authored by Viral N. Shah, Edward Franek, Karin Wernicke-Panten, Suzanne Pierre, Bhaswati Mukherjee, Karita Sadeharju

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Diabetes Therapy

    Categories

    Keywords

    Biosimilar insulinGEMELLI 1Insulin aspartSAR341402Subgroup by prior mealtime insulin

    Licence

    CC BY-NC 4.0

    Exports